Business

May 13, 2014

Heat Biologics reports $2.3 million first quarter loss

Heat Biologics reported a net loss in the first quarter as the small Chapel Hill drug-development prepares to begin Phase 2 trails for its lung cancer treatment later this year.

Related content

Comments

Videos

Editor's Choice Videos